Literature DB >> 20031093

Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression.

Stephen M Stahl1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031093     DOI: 10.4088/JCP.09bs05697blu

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

1.  L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode.

Authors:  Lawrence D Ginsberg; Alondra Y Oubre; Yahya A Daoud
Journal:  Innov Clin Neurosci       Date:  2011-01

2.  Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor.

Authors:  Thomas L Schwartz; Umar A Siddiqui; Stephen M Stahl
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

3.  Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.

Authors:  Kyung-Yeol Bae; Sung-Wan Kim; Jae-Min Kim; Il-Seon Shin; Jin-Sang Yoon; Sung-Won Jung; Min-Soo Lee; Hyeon-Woo Yim; Tae-Youn Jun
Journal:  Psychiatry Investig       Date:  2011-08-26       Impact factor: 2.505

4.  Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.

Authors:  Mandeep Singh; Thomas L Schwartz
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-23       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.